Logo image of AUST

AUSTIN GOLD CORP (AUST) Stock Fundamental Analysis

NYSEARCA:AUST - NYSE Arca - CA05223F1062 - Common Stock - Currency: USD

1.38  +0.05 (+3.76%)

After market: 1.33 -0.05 (-3.62%)

Fundamental Rating

3

Overall AUST gets a fundamental rating of 3 out of 10. We evaluated AUST against 151 industry peers in the Metals & Mining industry. AUST has a great financial health rating, but its profitability evaluates not so good. AUST has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year AUST has reported negative net income.
AUST had a negative operating cash flow in the past year.
AUST Yearly Net Income VS EBIT VS OCF VS FCFAUST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -1M -2M -3M -4M

1.2 Ratios

AUST has a Return On Assets of -40.59%. This is amonst the worse of the industry: AUST underperforms 84.11% of its industry peers.
AUST's Return On Equity of -41.05% is on the low side compared to the rest of the industry. AUST is outperformed by 78.15% of its industry peers.
Industry RankSector Rank
ROA -40.59%
ROE -41.05%
ROIC N/A
ROA(3y)-18.66%
ROA(5y)N/A
ROE(3y)-19.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AUST Yearly ROA, ROE, ROICAUST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AUST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AUST Yearly Profit, Operating, Gross MarginsAUST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, AUST has about the same amount of shares outstanding.
There is no outstanding debt for AUST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AUST Yearly Shares OutstandingAUST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
AUST Yearly Total Debt VS Total AssetsAUST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M

2.2 Solvency

AUST has an Altman-Z score of 97.54. This indicates that AUST is financially healthy and has little risk of bankruptcy at the moment.
AUST's Altman-Z score of 97.54 is amongst the best of the industry. AUST outperforms 97.35% of its industry peers.
There is no outstanding debt for AUST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 97.54
ROIC/WACCN/A
WACCN/A
AUST Yearly LT Debt VS Equity VS FCFAUST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

AUST has a Current Ratio of 55.52. This indicates that AUST is financially healthy and has no problem in meeting its short term obligations.
AUST has a better Current ratio (55.52) than 99.34% of its industry peers.
AUST has a Quick Ratio of 55.52. This indicates that AUST is financially healthy and has no problem in meeting its short term obligations.
AUST has a better Quick ratio (55.52) than 99.34% of its industry peers.
Industry RankSector Rank
Current Ratio 55.52
Quick Ratio 55.52
AUST Yearly Current Assets VS Current LiabilitesAUST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

The earnings per share for AUST have decreased strongly by -16.17% in the last year.
EPS 1Y (TTM)-16.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-224.55%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y50.11%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AUST Yearly Revenue VS EstimatesAUST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024
AUST Yearly EPS VS EstimatesAUST Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -0.1 -0.2 -0.3

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AUST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AUST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AUST Price Earnings VS Forward Price EarningsAUST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AUST Per share dataAUST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AUST!.
Industry RankSector Rank
Dividend Yield N/A

AUSTIN GOLD CORP

NYSEARCA:AUST (3/7/2025, 8:06:12 PM)

After market: 1.33 -0.05 (-3.62%)

1.38

+0.05 (+3.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)03-12 2025-03-12/amc
Inst Owners1.64%
Inst Owner Change-13.86%
Ins Owners50.11%
Ins Owner ChangeN/A
Market Cap18.31M
Analysts82.86
Price TargetN/A
Short Float %0.26%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB 1.86
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0
BVpS0.74
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.59%
ROE -41.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.66%
ROA(5y)N/A
ROE(3y)-19.46%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 146631%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 55.52
Quick Ratio 55.52
Altman-Z 97.54
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)224793%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-224.55%
EPS Next Y50.11%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.79%
OCF growth 3YN/A
OCF growth 5YN/A